Skip to main content

Rabbit Polyclonal IFI35 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human, Recombinant full length protein - Human, Pig samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human IFI35 aa 1 to C-terminus.

Be the first to review this product! Submit a review

Images

Western blot - Anti-IFI35 antibody (AB233415), expandable thumbnail
  • Western blot - Anti-IFI35 antibody (AB233415), expandable thumbnail
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFI35 antibody (AB233415), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Anti-IFI35 antibody (AB233415), expandable thumbnail

Publications

  • International journal of molecular medicine 47:2021
    IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins.
    Applications:
    Unspecified application
    Reactive species:
    Unspecified reactive species
    Xiaohui Xu,Yong Wu,Ke Yi,Yan Hu,Weiqun Ding,Chungen Xing
    PubMed 33907823

Key facts

Isotype

IgG

Host species

Rabbit

Storage buffer

pH: 7.4
Preservative: 0.011% Proclin 300
Constituents: 55.77% Glycerol (glycerin, glycerine), 44.219% PBS

Form

Liquid

Clonality

Polyclonal

Immunogen

  • Recombinant Fragment Protein within Human IFI35 aa 1 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link P80217

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
WBIHC-PICC/IF
Human
Tested
Tested
Tested
Pig
Tested
Expected
Expected
Recombinant full length protein - Human
Tested
Not recommended
Not recommended

Tested
Tested

Species

Human

Dilution info

0.2-2 µg/mL

Notes

-

Species

Recombinant full length protein - Human

Dilution info

0.2-2 µg/mL

Notes

-

Species

Pig

Dilution info

0.2-2 µg/mL

Notes

-

Tested
Tested

Species

Human

Dilution info

5-20 µg/mL

Notes

-

Expected
Expected

Species

Pig

Dilution info

Use at an assay dependent concentration.

Notes

-

Not recommended
Not recommended

Species

Recombinant full length protein - Human

Dilution info

-

Notes

-

Tested
Tested

Species

Human

Dilution info

5-20 µg/mL

Notes

-

Expected
Expected

Species

Pig

Dilution info

Use at an assay dependent concentration.

Notes

-

Not recommended
Not recommended

Species

Recombinant full length protein - Human

Dilution info

-

Notes

-

Associated Products

Select an associated product type

2 products for Alternative Product

Target data

Function

Acts as a signaling pathway regulator involved in innate immune system response (PubMed:26342464, PubMed:29038465, PubMed:29350881). In response to interferon IFN-alpha, associates in a complex with signaling pathway regulator NMI to regulate immune response; the complex formation prevents proteasome-mediated degradation of IFI35 and correlates with IFI35 dephosphorylation (PubMed:10779520, PubMed:10950963). In complex with NMI, inhibits virus-triggered type I interferon/IFN-beta production (PubMed:26342464). In complex with NMI, negatively regulates nuclear factor NF-kappa-B signaling by inhibiting the nuclear translocation, activation and transcription of the NF-kappa-B subunit p65/RELA, resulting in the inhibition of endothelial cell proliferation, migration and re-endothelialization of injured arteries (PubMed:29350881). Beside its role as an intracellular signaling pathway regulator, also functions extracellularly as damage-associated molecular patterns (DAMPs) to promote inflammation when actively released by macrophage to the extracellular space during cell injury and pathogen invasion (PubMed:29038465). Macrophage-secreted IFI35 activates NF-kappa-B signaling in adjacent macrophages through Toll-like receptor 4/TLR4 activation, thereby inducing NF-kappa-B translocation from the cytoplasm into the nucleus which promotes the release of proinflammatory cytokines (PubMed:29038465).

Alternative names

Recommended products

  1. Loading...
  2. Loading...
  3. Loading...
  4. Loading...

Rabbit Polyclonal IFI35 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human, Recombinant full length protein - Human, Pig samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human IFI35 aa 1 to C-terminus.

Alternative names

Key facts

Isotype

IgG

Form

Liquid

Clonality

Polyclonal

Immunogen
  • Recombinant Fragment Protein within Human IFI35 aa 1 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link P80217
Purification technique

Affinity purification Immunogen

Concentration
Loading...
Purification notes

Antigen-specific affinity chromatography followed by Protein A affinity chromatography.

Storage

Shipped at conditions

Blue Ice

Appropriate short-term storage duration

1-2 weeks

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

-20°C

Aliquoting information

Upon delivery aliquot

Storage information

Avoid freeze / thaw cycle

Notes

Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.

If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.

Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.

Supplementary info

Activity summary

IFI35 also known as Interferon-induced 35 kDa protein plays a role mechanically in the regulation of immune responses. It has a molecular mass of approximately 35 kDa. This protein is expressed in various tissues with high levels found in the liver lungs and spleen. IFI35 interacts with numerous proteins particularly within the cytoplasm to execute its functions.

Biological function summary

The protein modulates the innate immune system and interacts with other interferon-induced proteins. It forms a complex with NMI (N-Myc interactor) which stabilizes each other. Through these interactions IFI35 contributes to antiviral defense mechanisms and possibly acts in response to cellular stress.

Pathways

IFI35 engages in the interferon signaling pathway and the Jak-STAT pathway. These pathways play critical roles in mediating immune responses to viral infections. IFI35 works together with related proteins like STAT1 and NMI within these pathways providing a framework for antiviral activity and influence on cell survival.

Associated diseases and disorders

IFI35 has associations with viral infections and autoimmune diseases. Viral pathogenesis can see modulation by IFI35 particularly infections caused by the hepatitis C virus. Furthermore its interaction with NMI may also play a part in autoimmune disorders by influencing inflammatory responses. These links highlight IFI35's significant contributions to disease mechanisms and therapeutic potential in managing immune-related conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

4 product images

  • Western blot - Anti-IFI35 antibody (ab233415), expandable thumbnail

    Western blot - Anti-IFI35 antibody (ab233415)

    All lanes: Western blot - Anti-IFI35 antibody (ab233415) at 2 µg/mL

    All lanes: Recombinant human IFI35 protein

    Secondary

    All lanes: HRP-Linked Guinea pig anti-Rabbit at 1/2000 dilution

    Predicted band size: 32 kDa

  • Western blot - Anti-IFI35 antibody (ab233415), expandable thumbnail

    Western blot - Anti-IFI35 antibody (ab233415)

    All lanes: Western blot - Anti-IFI35 antibody (ab233415) at 2 µg/mL

    Lane 1: Human lung lysate

    Lane 2: HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate

    Lane 3: Pig liver lysate

    Secondary

    All lanes: HRP-Linked Guinea pig anti-Rabbit at 1/2000 dilution

    Predicted band size: 32 kDa

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFI35 antibody (ab233415), expandable thumbnail

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IFI35 antibody (ab233415)

    Formalin-fixed, paraffin-embedded human liver tissue stained for IFI35 using ab233415 at 10 μg/ml in immunohistochemical analysis. DAB staining.

  • Immunocytochemistry/ Immunofluorescence - Anti-IFI35 antibody (ab233415), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-IFI35 antibody (ab233415)

    HeLa (human epithelial cell line from cervix adenocarcinoma) cells stained for IFI35 (green) using ab233415 at 20 μg/ml in ICC/IF. FITC staining.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com